Wealth Enhancement Advisory Services, LLC Lexaria Bioscience Corp. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 30,959 shares of LEXX stock, worth $27,243. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,959
Previous 28,873
7.22%
Holding current value
$27,243
Previous $60,000
13.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LEXX
# of Institutions
24Shares Held
1.28MCall Options Held
0Put Options Held
0-
Invenomic Capital Management LP Boston, MA550KShares$483,9530.05% of portfolio
-
Geode Capital Management, LLC Boston, MA172KShares$151,7620.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6130KShares$114,4220.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA128KShares$112,5260.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL61.3KShares$53,9000.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $5.24M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...